Receptor, Melanocortin, Type 4, agonists

Name
Receptor, Melanocortin, Type 4, agonists
Accession Number
DBCAT002830
Description
Not Available
Drugs
DrugDrug Description
BremelanotideBremelanotide is indicated to treat premenopausal women with hypoactive sexual desire disorder that is not due to a medical or psychiatric condition, problems with the relationship, or the effects of...
SetmelanotideSetmelanotide has been investigated for the treatment of obesity.
PF-00446687PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Drugs & Drug Targets
DrugTargetType
BremelanotideMelanocyte-stimulating hormone receptortarget
BremelanotideMelanocortin receptor 4target
BremelanotideMelanocortin receptor 3target
BremelanotideMelanocortin receptor 5target
BremelanotideAdrenocorticotropic hormone receptortarget